Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Prevents the development of necrosis of many tissues
This C-terminal fragment is used in research to investigate mechanisms of lipid metabolism and adipocyte biology, including experimentally reported effects on lipolysis and related pathways, without the full spectrum of growth-promoting activity associated with the intact hGH molecule
Retatrutide (development code LY3437943) is a 39-amino acid synthetic peptide developed by Eli Lilly as the first triple-receptor agonist targeting GLP-1R, GIPR, and GCGR in a single molecule
Peptides: Peptides like BPC-157, KPV, and Thymosin Alpha-1 are generally very well-tolerated
Comparing their side-effect profiles requires cross-study synthesis, not direct data
US$ 28.87
US$ 29.90
US$ 27.46
US$ 22.43
US$ 24.70
US$ 21.23
US$ 28.52
US$ 27.46
